Aim: This study aimed to assess adherence to pharmacological and non-pharmacological treatments, hospital stay duration, and related risk factors in patients hospitalized with COPD and asthma exacerbations.Methods: A cross-sectional study was conducted between January and March 2023, including patients admitted to the chest diseases department with a diagnosis of COPD or asthma exacerbation. Patients with community-acquired pneumonia, without a known diagnosis of asthma or COPD, were used as a control group. A validated questionnaire adapted from Jeong et al. was used to evaluate treatment adherence. The COPD and asthma groups were compared with the control group. T-tests and chi-square tests were used for statistical analysis.Results: A total of 30 COPD, 12 asthma, and 17 pneumonia patients were included. The overall mean age was 52.9±10.9 years, and 73% were male. COPD patients were significantly older (p=0.04), predominantly male (p
Durak et al. (Tue,) studied this question.